Personalis, Inc. (PSNL)
NASDAQ: PSNL · IEX Real-Time Price · USD
3.850
+1.400 (57.14%)
At close: Jul 19, 2024, 4:00 PM
3.580
-0.270 (-7.01%)
Pre-market: Jul 22, 2024, 7:28 AM EDT
Personalis Market Cap
Personalis has a market cap or net worth of $199.96 million as of July 22, 2024. Its market cap has increased by 137.49% in one year.
Market Cap
199.96M
Enterprise Value
141.98M
1-Year Change
137.49%
Ranking
Category
Stock Price
$3.85
Market Cap Chart
Since June 20, 2019, Personalis's market cap has decreased from $811.90M to $199.96M, a decrease of -75.37%. That is a compound annual growth rate of -24.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 200.00M | 94.17% |
| Dec 29, 2023 | 103.00M | 13.19% |
| Dec 30, 2022 | 91.00M | -85.76% |
| Dec 31, 2021 | 639.10M | -55.16% |
| Dec 31, 2020 | 1.43B | 318.59% |
| Dec 31, 2019 | 340.50M | -58.06% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pyxis Oncology | 204.93M |
| Biodesix | 202.99M |
| bluebird bio | 202.38M |
| CVRx, Inc. | 202.13M |
| Outset Medical | 200.17M |
| Renovaro Biosciences | 199.13M |
| P3 Health Partners | 197.60M |
| Trevi Therapeutics | 195.81M |